首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Albumin to ascites: demonstration of a direct pathway bypassing the systemic circulation
【2h】

Albumin to ascites: demonstration of a direct pathway bypassing the systemic circulation

机译:腹水的白蛋白:绕过全身循环的直接途径的证明

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The transport of plasma albumin and newly made albumin into ascitic fluid was studied in eight patients with cirrhosis and ascites. The thoracic duct was cannulated in two patients and lymph collected over a period of 2 hr. Simultaneously albumin-131I and carbonate-14C were injected intravenously. The albumin-131I measured the transfer of plasma albumin into ascites and into thoracic duct lymph. The carbonate-14C, by labeling newly formed albumin, permitted the estimation of the transfer of newly formed albumin into plasma, ascites, and lymph.If the newly synthesized albumin entering ascites and thoracic duct lymph is delivered initially into the plasma, then the ratios of the albumin-14C and -131I in ascites and lymph compared with the content of albumin-14C and -131I in plasma would be identical. However, if some newly formed albumin is delivered directly into ascites or lymph, the ratio for albumin-14C would be higher than that for albumin-131I in lymph or ascites.The ratios of both labeled albumins found in ascites or lymph are expressed as per cent of the total plasma pool. In the eight patients studied 4.2-11.7% of the albumin-14C in plasma was found in ascites in 2 hr whereas only 0.4-2.2% of plasma albumin-131I entered in this same period. In the two patients studied during thoracic duct lymph drainage 6.1 and 13.5% of newly made albumin-14C appeared in lymph in 2 hr whereas only 2.8 and 3.8% of plasma albumin-131I was found in the lymph.In cirrhosis with ascites some newly formed albumin entered ascites and thoracic duct lymph by a direct pathway from the liver bypassing the systemic circulation.
机译:研究了八名肝硬化和腹水患者的血浆白蛋白和新生白蛋白向腹水的转运。两名患者插入了胸导管,并在2小时内收集了淋巴液。同时静脉注射白蛋白- 131 I和碳酸盐- 14 C。白蛋白- 131 I测定了血浆白蛋白向腹水和胸导管淋巴中的转移。碳酸盐 14 C通过标记新形成的白蛋白,可以估计新形成的白蛋白向血浆,腹水和淋巴中的转移。如果新合成的白蛋白进入腹水和胸导管淋巴首先进入血浆,然后在腹水和淋巴中白蛋白- 14 C和- 131 I的比率与白蛋白- 14 C和- 131 I相同。但是,如果将一些新形成的白蛋白直接递送至腹水或淋巴中,则淋巴或腹水中白蛋白- 14 C的比率将高于白蛋白- 131 I在腹水或淋巴中发现的两种标记白蛋白的比率表示为总血浆池的百分比。在八名研究的患者中,腹水在2小时内发现血浆中白蛋白- 14 C的4.2-11.7%,而血浆白蛋白- 131 I的仅为0.4-2.2%在同一时期输入。在研究的两名患者的胸导管淋巴引流中,新产生的白蛋白- 14 C的6.1和13.5%在2小时内出现在淋巴中,而血浆白蛋白- 131 的只有2.8%和3.8%在肝硬化腹水中,一些新形成的白蛋白通过肝脏绕过全身循环的直接途径进入腹水和胸导管淋巴。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号